Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone
Sam W Z Olechnowicz1,2,3, Megan M Weivoda2, Seint T Lwin1,2
1Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Abstract:
Interactions between multiple myeloma (MM) and bone marrow (BM) are well documented to support tumour growth, yet the cellular mechanisms underlying pain in MM are poorly understood. We have used in vivo murine models of MM to show significant induction of nerve growth factor (NGF) by the tumour-bearing bone microenvironment, alongside other known pain-related characteristics such as spinal glial cell activation and reduced locomotion. NGF was not expressed by MM cells, yet bone stromal cells such as osteoblasts expressed and upregulated NGF when cultured with MM cells, or MM-related factors such as TNF-α. Adiponectin is a known MM-suppressive BM-derived factor, and we show that TNF-α-mediated NGF induction is suppressed by adiponectin-directed therapeutics such as AdipoRON and L-4F, as well as NF-κB signalling inhibitor BMS-345541. Our study reveals a further mechanism by which cellular interactions within the tumour-bone microenvironment contribute to disease, by promoting pain-related properties, and suggests a novel direction for analgesic development.
Insights
Multiple myeloma (MM) induces nerve growth factor (NGF) in the bone microenvironment, contributing to pain. Adiponectin-based therapies can suppress this NGF induction, offering a new avenue for pain management.
Area of Science:
- Oncology
- Neuroscience
- Biochemistry
Background:
- Interactions between multiple myeloma (MM) and bone marrow (BM) support tumor growth.
- The cellular mechanisms of pain in MM are not well understood.
Purpose of the Study:
- To investigate the cellular mechanisms underlying pain in multiple myeloma.
- To identify novel therapeutic targets for pain management in MM.
Main Methods:
- In vivo murine models of MM were utilized.
- Expression of nerve growth factor (NGF) and related pain markers were analyzed.
- The effects of adiponectin-directed therapeutics and NF-κB signaling inhibitors were evaluated.
Main Results:
- Significant induction of NGF by the tumor-bearing bone microenvironment was observed.
- Osteoblasts, not MM cells, expressed and upregulated NGF in response to MM cells or TNF-α.
- Adiponectin-directed therapeutics (AdipoRON, L-4F) and BMS-345541 suppressed TNF-α-mediated NGF induction.
Conclusions:
- Cellular interactions in the MM-bone microenvironment promote pain-related properties via NGF induction.
- Adiponectin-based therapies and NF-κB inhibitors show potential for developing novel analgesics for MM-related pain.
More Related Videos
Related Concept Videos
Blood and Nerve Supply to the Bones
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
The Tumor Microenvironment


